Select an image below for information



Andrew Posselt M.D, Ph.D

Peter Stock, M.D, Ph.D
Director of Pancreas Transplantation, Co-Director of the Islet Transplant Program at UCSF


Read more about UCSF Medical Center's Transplant Options for Type 1 Diabetes >>


For information about islet trials call the nurse coordinator at 415.353.8893.








 

Because islet transplantation is minimally invasive, it can be offered to patients with severe cardiovascular disease who cannot tolerate open surgery, says Andrew Posselt M.D, Ph.D, head of the Pancreas and Pancreatic Islet Transplant Program. However, islet transplants generally do not last as long as solid organ pancreas transplants. The beta cells appear to stop working after a period of time, requiring an additional infusion from another donor.